Cargando…

HLA-F Allele-Specific Peptide Restriction Represents an Exceptional Proteomic Footprint

Peptide-dependent engagement between human leucocyte antigens class I (HLA-I) molecules and their cognate receptors has been extensively analyzed. HLA-F belongs to the non-classical HLA-Ib molecules with marginal polymorphic nature and tissue restricted distribution. The three common allelic variant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hò, Gia-Gia T., Heinen, Funmilola J., Blasczyk, Rainer, Pich, Andreas, Bade-Doeding, Christina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888383/ https://www.ncbi.nlm.nih.gov/pubmed/31717259 http://dx.doi.org/10.3390/ijms20225572

Ejemplares similares

The Loss of HLA-F/KIR3DS1 Ligation Is Mediated by Hemoglobin Peptides
por: Hò, Gia-Gia T., et al.
Publicado: (2020)

HLA-F*01:01 presents peptides with N-terminal flexibility and a preferred length of 16 residues
por: Hò, Gia-Gia T., et al.
Publicado: (2019)

Releasing the concept of HLA‐allele specific peptide anchors in viral infections: A non‐canonical naturally presented human cytomegalovirus‐derived HLA‐A*24:02 restricted peptide drives exquisite immunogenicity
por: Pump, Wiebke C., et al.
Publicado: (2019)

Between Innate and Adaptive Immune Responses: NKG2A, NKG2C, and CD8(+) T Cell Recognition of HLA-E Restricted Self-Peptides Acquired in the Absence of HLA-Ia
por: Pump, Wiebke C., et al.
Publicado: (2019)

Unravelling the Proteomics of HLA-B*57:01(+) Antigen Presenting Cells during Abacavir Medication
por: Haukamp, Funmilola Josephine, et al.
Publicado: (2022)

The Mechanistic Differences in HLA-Associated Carbamazepine Hypersensitivity
por: Simper, Gwendolin S., et al.
Publicado: (2019)

NKG2A/CD94 Is a New Immune Receptor for HLA-G and Distinguishes Amino Acid Differences in the HLA-G Heavy Chain
por: Hò, Gia-Gia T., et al.
Publicado: (2020)

Soluble HLA Technology as a Strategy to Evaluate the Impact of HLA Mismatches
por: Kunze-Schumacher, Heike, et al.
Publicado: (2014)

HLA-E: A Novel Player for Histocompatibility
por: Kraemer, Thomas, et al.
Publicado: (2014)

Battle between Host Immune Cellular Responses and HCMV Immune Evasion
por: Manandhar, Trishna, et al.
Publicado: (2019)

A Micropolymorphism Altering the Residue Triad 97/114/156 Determines the Relative Levels of Tapasin Independence and Distinct Peptide Profiles for HLA-A(*)24 Allotypes
por: Badrinath, Soumya, et al.
Publicado: (2014)

Carbamazepine-Mediated Adverse Drug Reactions: CBZ-10,11-epoxide but Not Carbamazepine Induces the Alteration of Peptides Presented by HLA-B∗15:02
por: Simper, Gwendolin S., et al.
Publicado: (2018)

Understanding the obstacle of incompatibility at residue 156 within HLA-B*35 subtypes
por: Manandhar, Trishna, et al.
Publicado: (2016)

The diversity of the HLA-E-restricted peptide repertoire explains the immunological impact of the Arg107Gly mismatch
por: Celik, Alexander A., et al.
Publicado: (2015)

HLA-B*57:01/Carbamazepine-10,11-Epoxide Association Triggers Upregulation of the NFκB and JAK/STAT Pathways
por: Haukamp, Funmilola Josephine, et al.
Publicado: (2023)

The polymorphism at residue 156 determines the HLA-B*35 restricted peptide repertoire during HCMV infection
por: Abels, Wiebke C., et al.
Publicado: (2018)

Proteomic Profiling and T Cell Receptor Usage of Abacavir Susceptible Subjects
por: Gall, Eline, et al.
Publicado: (2022)

HLA-G peptide preferences change in transformed cells: impact on the binding motif
por: Celik, Alexander A., et al.
Publicado: (2018)

The microstructure in the placenta is influenced by the functional diversity of HLA-G allelic variants
por: Stieglitz, F., et al.
Publicado: (2019)

HLA-E: Presentation of a Broader Peptide Repertoire Impacts the Cellular Immune Response—Implications on HSCT Outcome
por: Kraemer, Thomas, et al.
Publicado: (2015)

Soluble HLA-G and HLA-G Bearing Extracellular Vesicles Affect ILT-2 Positive and ILT-2 Negative CD8 T Cells Complementary
por: Schwich, Esther, et al.
Publicado: (2020)

Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection
por: Fitzmaurice, Karen, et al.
Publicado: (2011)

Generation of HLA Universal Megakaryocytes and Platelets by Genetic Engineering
por: Figueiredo, Constanca, et al.
Publicado: (2021)

HLA autoimmune risk alleles restrict the hypervariable region of T cell receptors
por: Ishigaki, Kazuyoshi, et al.
Publicado: (2022)

Frequencies of Gag-restricted T-cell escape “footprints” differ across HIV-1 clades A1 and D chronically infected Ugandans irrespective of host HLA B alleles()
por: Serwanga, Jennifer, et al.
Publicado: (2015)

HLA-E restricted cytomegalovirus UL40 peptide polymorphism may represent a risk factor following congenital infection
por: Tarragó, David, et al.
Publicado: (2022)

Divergent Peptide Presentations of HLA-A(*)30 Alleles Revealed by Structures With Pathogen Peptides
por: Zhu, Shiyan, et al.
Publicado: (2019)

The HLA Class II Allele DRB1*1501 Is Over-Represented in Patients with Idiopathic Pulmonary Fibrosis
por: Xue, Jianmin, et al.
Publicado: (2011)

Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles
Publicado: (1993)

Immunological evaluation of peptide vaccination for cancer patients with the HLA-A26 allele
por: Sakamoto, Shinjiro, et al.
Publicado: (2015)

Association of HLA alleles with autism
por: Sayad, Arezou, et al.
Publicado: (2018)

The mutational footprints of cancer therapies
por: Pich, Oriol, et al.
Publicado: (2019)

HLA Heterozygote Advantage against HIV-1 Is Driven by Quantitative and Qualitative Differences in HLA Allele-Specific Peptide Presentation
por: Arora, Jatin, et al.
Publicado: (2020)

PyHLA: tests for the association between HLA alleles and diseases
por: Fan, Yanhui, et al.
Publicado: (2017)

KIR-HLA footprints and NK cell-mediated recognition of HIV-1
por: Thobakgale, CF, et al.
Publicado: (2012)

Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles
por: Pavlos, Rebecca, et al.
Publicado: (2017)

Comparison of HLA allelic imputation programs
por: Karnes, Jason H., et al.
Publicado: (2017)

Association of HLA-A and Non-Classical HLA Class I Alleles
por: Carlini, Federico, et al.
Publicado: (2016)

Structure of HLA-A*0301 in complex with a peptide of proteolipid protein: insights into the role of HLA-A alleles in susceptibility to multiple sclerosis
por: McMahon, Róisín M., et al.
Publicado: (2011)

Immunological evaluation of peptide vaccination for cancer patients with the HLA ‐A11(+) or ‐A33(+) allele
por: Sakamoto, Shinjiro, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6froh1oj4ltleetrn7f6s8ngv0